A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

Gov. Gavin Newsom's budget plan walks back his promise to provide free healthcare to undocumented immigrants, caps overtime ...

President Donald Trump on Monday signed an executive order reviving a controversial plan to lower prescription drug costs by ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look ...

The report runs an in-depth analysis of market trends, key players, and future opportunities. The generic drugs market comprises a range of drugs use ...

California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program. Instead, the state opted to include them. Under Newsom’s proposed cuts, when Ozempic is ...